Biohub, the organization financially backed by Mark Zuckerberg and Priscilla Chan, has announced the launch of the $500 million “Virtual Biology Initiative.” The massive investment aims to build advanced artificial intelligence models capable of accurately simulating human cell behavior in a virtual environment, a move expected to radically accelerate drug discovery for the most severe diseases

Read More

American startup OpenEvidence has scrapped plans to enter the European Union and UK markets, citing fears over the fallout from the AI Act. However, developers of European AI systems explain why these stringent regulations – while deterring global players – are ultimately meant to build the world’s safest medical ecosystem.

Read More